Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Insulin Insitu-gel as a Wound Healing Accelerator and Anti-inflammatory Agent for Persistent Suppurative Otitis Media in RCT

NCT07535827 is registered in ClinicalTrials.gov with Deraya University as lead sponsor.

NCT NCT07535827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07535827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Insulin Insitu-gel as a Wound Healing Accelerator and Anti-inflammatory Agent for Persistent Suppurative Otitis Media in RCT
Lead sponsor
Deraya University
Phase
Phase 1
Overall status
Completed
Start date
March 20, 2026
Completion date
May 30, 2026
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tympanic membrane perforation